Loading…
CVRx, Inc.
CVRx, Inc. (CVRX) is listed on NASDAQ and classified in Medical Devices, part of the Healthcare sector. It is headquartered in Minneapolis, United States and has 223 employees. The company is worth $34.63M. Revenue was $56.65M in fiscal 2025, up 10.4% from the year before. It reported a net loss of $53.31M. The share price is 88.5% below its 52-week high of $11.30. 6 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Renaissance Technologies, at $1.18M. In that quarter, 1 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -88.8% over 5Y.
today you would have $76.88▼ -92.3%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 5 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $7.10 | $12.67 | $31.44 | $18.35 | $12.23 | |
| P/S | 16.7x | 3.3x | 6.4x | 16.7x | 16.9x | 19.2x |
| P/B | 4.6x | 4.8x | 4.6x | 8.7x | 3.5x | 1.7x |
| EPS | -$2.04 | -$2.65 | -$1.99 | -$2.02 | -$4.16 | |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| EDSAEdesa Biotech, Inc. | $2.57 | — | 62.7x | 0.00% | -122.93% | $34.72M |
| QTIQt Imaging Holdings Inc | $2.40 | — | 14.7x | 0.00% | -2125.30% | $35.13M |
| ELUTElutia Inc | $0.79 | — | 2.2x | 0.00% | — | $35.17M |
| NNVCNanoviricides Inc | $1.38 |
| Profit margin |
| -116.91% |
| -94.10% |
| -116.91% |
| -104.85% |
| -184.38% |
| -330.45% |
| ROE | -54.25% | -135.56% | -84.39% | -54.25% | -37.94% | -29.51% |
Median of the years shown; P/E years above 200x are left out.
| — |
| 3.7x |
| 0.00% |
| -101.46% |
| $35.22M |
| FLNAFilana Therapeutics Inc | $0.70 | — | 0.5x | 0.00% | -55.78% | $33.98M |
| IXHLIncannex Healthcare Inc. | $2.82 | — | 0.5x | 0.00% | -47.80% | $35.38M |